Cut jobs not likely to reappear

Pharma's shift into emerging markets and away from established sales and marketing routines leads to permanent job cuts, says The Economist. That's in contrast to job cuts that normally accompany a recession, which are reversible when the economy improves.  Jobs that are disappearing now will probably not reappear, but that may help save other jobs by shoring up pharma company profits. Article

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.